Improving therapeutic resistance: beginning with targeting the tumor microenvironment.
- Published in:
- Journal of Chemotherapy (Taylor & Francis Ltd), 2022, v. 34, n. 8, p. 492, doi. 10.1080/1120009X.2021.2011661
- By:
- Publication type:
- Article
Works by Jiao, Zuo-yi
Results: 4
1
2
Ruthenium‐Catalyzed Double C(sp<sup>2</sup>)−H Functionalizations of Fumaramides with Alkynes for the Divergent Synthesis of Pyridones and Naphthyridinediones.
- Published in:
- ChemCatChem, 2020, v. 12, n. 9, p. 2538, doi. 10.1002/cctc.201902160
- By:
- Publication type:
- Article
3
Duodenal Bulb Adenocarcinoma Benefitted from Neoadjuvant Chemotherapy: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 5, p. 290, doi. 10.1159/000469700
- By:
- Publication type:
- Article
4
Identification of key genes and associated pathways in KIT/PDGFRA wild-type gastrointestinal stromal tumors through bioinformatics analysis.
- Published in:
- Molecular Medicine Reports, 2018, v. 18, n. 5, p. 4499, doi. 10.3892/mmr.2018.9457
- By:
- Publication type:
- Article